COPD patients get relief from inhaled corticosteroids
Patients with Chronic obstructive pulmonary disease (COPD) and being administered with corticosteroids are less likely to struggle when it comes to the mortality risk factor, as per a new study published in the CHEST, peer-reviewed journal of the American College of Chest Physicians (ACCP).
The survival rate of these patients gets improved by a considerable extent, according to Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada and author of this study.
From Bio-medicine.org:
“Our results indicate that the effect of inhaled corticosteroids is relatively short-term and that those currently using it are relatively better protected, ” said Dr. Macie. “Inhaled corticosteroids should be prescribed as soon as clinically indicated. By treating COPD with inhaled corticosteroids, we have the potential to reduce the effect and prolong life.”
“The findings from this study are intriguing for clinicians and point to the need for further research to define the role and mechanisms of the effect of inhaled corticosteroids on both cardiovascular and respiratory mortality,” said W. Michael Alberts, MD, FCCP, President of the ACCP.
Dr. Macie was quick to remark that COPD patients administered with corticosteroids showed far better improvements than those not making a use of them. It was also remarked that COPD patients (on corticosteroids paired with beta- agonists) experienced a 25 percent reduced all-cause mortality rate and 38 percent reduced death rate within 30 days of hospital discharge.
Tags: chronic obstructive pulmonary disease, COPD, decreased mortality risk, inhaled corticosteroids
Recent Comments